Novel clinical therapeutics targeting the epithelial to mesenchymal transition
Open Access
- 15 October 2014
- journal article
- review article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 3 (1) , 35
Abstract
The epithelial to mesenchymal transition (EMT) is implicated in many processes, ranging from tissue and organogenesis to cancer and metastatic spread. Understanding the key regulatory mechanisms and mediators within this process offers the opportunity to develop novel therapeutics with broad clinical applicability. To date, several components of EMT already are targeted using pharmacologic agents in fibrosis and cancer. As our knowledge of EMT continues to grow, the potential for novel therapeutics will also increase. This review focuses on the role of EMT both as a necessary part of development and a key player in disease progression, specifically the similarity in pathways used during both processes as targets for drug development. Also, the key role of the tumor microenvironment with EMT is outlined, focusing on both co‐factors and cell types with the ability to modulate the progression of EMT in cancer and metastatic disease. Lastly, we discuss the current status of clinical therapies both in development and those progressed to clinical trial specifically targeting pathologic EMTs including small molecule inhibitors, non‐coding RNAs, exogenous co‐factors, and adjunctive therapies to current chemotherapeutics.Keywords
This publication has 132 references indexed in Scilit:
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the BreastCell, 2011
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistanceDrug Resistance Updates, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Persistence of Leukemia-Initiating Cells in a Conditional Knockin Model of an Imatinib-Responsive Myeloproliferative DisorderCancer Cell, 2009
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer MetastasisCell, 2009
- Molecular characterisation of the tumour microenvironment in breast cancerEuropean Journal of Cancer, 2008
- Nicotine induces cell proliferation, invasion and epithelial‐mesenchymal transition in a variety of human cancer cell linesInternational Journal of Cancer, 2008
- Back and forth between cell fate specification and movement during vertebrate gastrulationCurrent Opinion in Genetics & Development, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT?Journal of Cellular Biochemistry, 2007